Other articles related with "R734":
  LU Juping, HU Jun, DENG Yongming, LIAO Shufang
  Downregulation of FKBP4 inhibits the malignant progression of non-small cell lung cancer by blocking the PI3K/Akt/mTOR signaling pathway
    Journal of Practical Oncology   2025 Vol.39 (3): 184-190 [Abstract] (64) [PDF 5756 KB] (21)
  GUO Xueyun, XU Yunfeng, CHU Shangqi, RUAN Fuxiang
  The correlation between EGF gene polymorphism and sensitivity of concurrent chemoradiotherapy regimen containing cisplatin in esophageal cancer patients
    Journal of Practical Oncology   2025 Vol.39 (3): 216-223 [Abstract] (44) [PDF 2325 KB] (4)
  LI Caizheng, ZHENG Jing, SU Qiaoli
  Advance progress in immunotherapy for unresectable locally advanced non-small cell lung cancer
    Journal of Practical Oncology   2025 Vol.39 (1): 67-72 [Abstract] (57) [PDF 902 KB] (72)
  XU Xianhui, CHEN Yang, ZHU Yunfang, LI Mingsong, WEN Hongmei
  Incidence and mortality of lung cancer in cancer registration areas of Yunnan province in 2020 and the trends from 2012 to 2020
    Journal of Practical Oncology   2024 Vol.38 (6): 367-371 [Abstract] (67) [PDF 1576 KB] (145)
  CHEN Xingyan, LI Xue, FU Qiang
  Research progress of RNA methylation in lung cancer
    Journal of Practical Oncology   2024 Vol.38 (6): 421-426 [Abstract] (81) [PDF 863 KB] (47)
  HAO Huiting, ZHAO Huijuan, XU Qiaohui
  Expression and clinical significance of hypermethylated in cancer 1 in non-small cell lung cancer
    Journal of Practical Oncology   2024 Vol.38 (5): 306-312 [Abstract] (59) [PDF 8359 KB] (7)
  XU Lingyan, LI Qianni, LI Jian, YAO Xuepei, LIU Meina
  Analysis for the impact of the first hospitalization days on treatment quality in patients with non-small cell lung cancer
    Journal of Practical Oncology   2024 Vol.38 (4): 221-226 [Abstract] (94) [PDF 2605 KB] (55)
  YAO Xuepei, BAI Shanqi, LIU Meina
  Analysis of factors influencing treatment quality of non-small cell lung cancer based on causal diagram model
    Journal of Practical Oncology   2024 Vol.38 (4): 227-234 [Abstract] (68) [PDF 3606 KB] (25)
  MA Na, LIU Jie
  Analysis of lung cancer incidence and mortality in Hedong district,Tianjin,from 2015 to 2020
    Journal of Practical Oncology   2024 Vol.38 (4): 241-245 [Abstract] (88) [PDF 1398 KB] (33)
  CHENG Yongming, DONG Huanhuan, XU Hui
  Hsa-let-7b-5p inhibits proliferation,migration and invasion in non-small cell lung cancer
    Journal of Practical Oncology   2024 Vol.38 (3): 157-167 [Abstract] (85) [PDF 23760 KB] (38)
  WANG Wenbo, BAI Haixin, ZHANG Tan, NIU Li
  Propofol inhibits glycolysis and tumor progression in lung cancer through GLUT4
    Journal of Practical Oncology   2024 Vol.38 (2): 104-111 [Abstract] (56) [PDF 14155 KB] (20)
  BO Yun, HANG Wenlu, ZUO Shurun, Dong Yuan, LI Haiquan
  Effects of long non-coding RNA OTUD6B-AS1 on proliferation,invasion and migration of lung adenocarcinoma A549 cells
    Journal of Practical Oncology   2024 Vol.38 (1): 13-17 [Abstract] (63) [PDF 2353 KB] (24)
  ZHANG Xuan, LI Xin, ZHAO Kang
  Relationship between serum inflammatory markers and prognosis of advanced non-small cell lung cancer patients treated with first-line immunosuppressants
    Journal of Practical Oncology   2024 Vol.38 (1): 37-44 [Abstract] (190) [PDF 4495 KB] (104)
  CAO Yingyue, PANG Luyi, ZHANG Jian, JIN Shi
  The role of cancer-associated fibroblasts in the progression of non-small cell lung cancer
    Journal of Practical Oncology   2023 Vol.37 (4): 383-388 [Abstract] (92) [PDF 12997 KB] (11)
  CHEN Qi, HE Mingxv, JIA Keliang, MIAO Jianlong, HAN Liping
  Research progress on the prognosis and treatment of non-small cell lung cancer with TP53-EGFR co-mutation
    Journal of Practical Oncology   2023 Vol.37 (3): 262-266 [Abstract] (90) [PDF 11057 KB] (21)
  LONG Chaolian, LI Kun, LIU Zichen, ZHANG Nana, CHE Nanying
  The correlation between the expression of programmed death ligand 1 in non-small cell lung cancer and clinical pathological features and common driver gene mutation
    Journal of Practical Oncology   2023 Vol.37 (2): 117-122 [Abstract] (75) [PDF 4614 KB] (31)
  XU Zihan, YU Guohua, NIE Yuhui, SUN Mengmeng, FENG Hui, LIU Shuzhen
  Predictive effect of peripheral blood markers on immune-related adverse reactions of advanced non-small cell lung cancer and their correlation with survival outcome
    Journal of Practical Oncology   2022 Vol.36 (6): 544-550 [Abstract] (90) [PDF 13391 KB] (23)
  CHEN Junhui, LIU Siyu, HE Changjun
  Research progress of RUNX1 in lung cancer
    Journal of Practical Oncology   2022 Vol.36 (6): 576-579 [Abstract] (178) [PDF 8631 KB] (41)
  ZHU Kaibin, HE Changjun, CHEN Lantao, KONG Xianglong, ZHAO Su, XU Shidong
  Tumor-associated macrophages promotes non-small cell lung cancer growth and tumor vascularization via PLGF/Flt-1 and TGF-β1 signal pathway
    Journal of Practical Oncology   2022 Vol.36 (5): 391-397 [Abstract] (134) [PDF 2295 KB] (70)
  WEN Xiaoxing, LIU Dahai, WU Xuehui, WANG Bingping, FANG Tao
  Knockdown osteopontin promotes gefitinib-resistence PC9 cells apoptosis
    Journal of Practical Oncology   2022 Vol.36 (4): 310-315 [Abstract] (181) [PDF 12525 KB] (46)
  SUN Weiling, ZHANG Minghui, WU Huaxing, ZHAO Yanbin
  Predictive value of serum tumor markers in histopathological types of bronchoscopy biopsy in patients with lung cancer
    Journal of Practical Oncology   2022 Vol.36 (4): 316-322 [Abstract] (138) [PDF 13491 KB] (46)
  LIAN Xiaomin, MA Feng, ZHAO Lixia, MENG Wei, ZHAO Dandan, ZHAO Junfeng
  Clinical comparative analysis of PD-1 inhibitor combined with anti-angiogenic drugs and chemotherapy in the second-line treatment of advanced lung adenocarcinoma
    Journal of Practical Oncology   2022 Vol.36 (4): 339-345 [Abstract] (211) [PDF 13421 KB] (39)
  DONG Lin, LIU Xin, LU Hailing
  Research progress of anti-angiogenic therapy combined with immune checkpoint inhibitors in advanced non-small cell lung cancer
    Journal of Practical Oncology   2022 Vol.36 (4): 351-355 [Abstract] (111) [PDF 10259 KB] (34)
  ZHANG Hao, YANG Xinguan, HE Yong
  Analysis of the correlation between sarcopenia and the clinicopathological characteristics and prognosis of advanced NSCLC
    Journal of Practical Oncology   2022 Vol.36 (3): 214-219 [Abstract] (128) [PDF 11637 KB] (33)
  ZHANG Mengru, CAO Dedong, GE Wei
  Comparison of efficacy and safety of Endostar intravenous continuous pumping and dripping combined with platinum-containing dual-drug regimen chemotherapy for the treatment of advanced non-small cell lung cancer
    Journal of Practical Oncology   2022 Vol.36 (1): 20-25 [Abstract] (152) [PDF 11711 KB] (34)
  BU Jianlong, ZHANG Pinyi, NI Boxiong, YU Xiran, NING Jinfeng
  Analysis of risk factors for lymph node metastasis in early lung adenocarcinoma
    Journal of Practical Oncology   2022 Vol.36 (1): 26-30 [Abstract] (214) [PDF 10165 KB] (67)
  LUO Wen, JIA Li, ZHANG Jiawen, WANG Dongjie, KONG Yingjun
  The effects of circRNA MYO1C on lung cancer cell autophagy and cancer stem cell differentiation
    Journal of Practical Oncology   2021 Vol.35 (6): 500-505 [Abstract] (104) [PDF 12584 KB] (42)
  WANG Ye, SHANG Naijian
  Application progress of radiomics in the diagnosis and treatment of non-small cell lung cancer
    Journal of Practical Oncology   2021 Vol.35 (5): 485-488 [Abstract] (86) [PDF 9486 KB] (27)
  WANG Junmei, PAN Huiqing, LI Jingyi, JIA Di, ZHAO Weiming, LV Changlian
  The expression and clinical significance of MT2-MMP at the stage II of lung adenocarcinoma
    Journal of Practical Oncology   2021 Vol.35 (3): 243-247 [Abstract] (207) [PDF 10721 KB] (89)
  YIN Lei, YANG Xudong, YANG Yue, NIU Xingjian, ZHOU Xiaoping, JI Hongfei, WANG Yiran
  The clinical significance and related mechanism of neutrophil to lymphocyte ratio in the prognostic evaluation of patients with non small cell lung cancer
    Journal of Practical Oncology   2021 Vol.35 (2): 117-124 [Abstract] (151) [PDF 14331 KB] (53)